Cargando…
Medtronic MiniMed 670G Auto Mode: Implications for Clinical Practice
Background: The Medtronic MiniMed 670G System was the first FDA approved hybrid closed loop system for users seven years of age and older. The system monitors glucose and can automatically adjust the delivery of long acting or basal insulin based on the user’s glucose reading while in Auto Mode. Pre...
Autores principales: | Dos Santos-Marinho, Jeanne, McGuirk, Liam, Puff, Amanda, Naparst, Monica, Alexandrov, Alice, Anselme, Philippe, Noto, Richard A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090581/ http://dx.doi.org/10.1210/jendso/bvab048.1349 |
Ejemplares similares
-
Medtronic MiniMed 670G Hybrid Closed-Loop System
por: Knebel, Tory, et al.
Publicado: (2019) -
Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review
por: Mameli, Chiara, et al.
Publicado: (2023) -
Commercialized Hybrid Closed-Loop System (Minimed Medtronic 670G) Results During Pregnancy
por: Moreno-Fernández, Jesús, et al.
Publicado: (2021) -
An Analysis of Medtronic Minimed 670g Insulin Pump Use in Clinical Practice and the Impact on Glycemic Control, Quality of Life, and Compliance
por: Horowitz, Maxwell E, et al.
Publicado: (2021) -
SAT-088 The Incidence of Neurological Symptoms During Growth Hormone Therapy in Patients with Chiari Malformation
por: Alexandrov, Alice, et al.
Publicado: (2020)